Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation
- PMID: 26270688
- PMCID: PMC4614415
- DOI: 10.1093/cid/civ665
Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation
Keywords: HIV prevention; PrEP; antiretrovirals; prophylaxis; tenofovir-emtricitabine.
Comment on
-
Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia.Clin Infect Dis. 2015 Nov 15;61(10):1590-7. doi: 10.1093/cid/civ664. Epub 2015 Aug 13. Clin Infect Dis. 2015. PMID: 26270691 Free PMC article. Review.
References
-
- Thigpen MC, Kebaabetswe PM, Paxton LA et al. . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423–34. - PubMed
-
- Choopanya K, Martin M, Suntharasamai P et al. . Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381:2083–90. - PubMed
-
- Grohskopf LA, Chillag KL, Gvetadze R et al. . Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr 2013; 64:79–86. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous